Clinically Occult Cecal Metastasis From Prostate Adenocarcinoma Detected by 18F-PSMA Positron Emission Tomography at Biochemical Recurrence

We present a patient with biochemical recurrence after salvage radiation and combined androgen deprivation therapy with abiraterone who underwent 18 F-PSMA PET/CT for a rapidly rising prostate-specific antigen (PSA). The scan revealed an intense prostate-specific membrane antigen (PSMA)-avid focus in the cecum without an apparent CT correlate. Colonoscopy identified a smooth, 2 cm nonobstructing cecal mass, and biopsy confirmed metastatic prostate adenocarcinoma by morphology and immunohistochemistry. This case demonstrates 18 F-PSMA PET/CT detection at a low PSA level of a clinically occult metastatic lesion involving the cecum, an exceptionally rare site for prostate cancer spread. Colonoscopy and biopsy confirmation of atypical PSMA-avid gastrointestinal lesions remain essential, as physiologic colonic uptake, PSMA-avid diverticula, and PSMA-expressing primary colorectal cancers are well-documented mimickers.

Authors

Publication Details

Journal
Clinical Nuclear Medicine
Published
2026-11-09
DOI
https://doi.org/10.1097/rlu.0000000000006785
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinically Occult Cecal Metastasis From Prostate Adenocarcinoma Detected by 18F-PSMA Positron Emission Tomography at Biochemical Recurrence

Ai Phuong Tong, Fatemeh (Sanaz) Behnia
Clinical Nuclear Medicine
Prostate Cancer Diagnosis and Treatment
article

Clinically Occult Cecal Metastasis From Prostate Adenocarcinoma Detected by 18F-PSMA Positron Emission Tomography at Biochemical Recurrence

Ai Phuong Tong, Fatemeh (Sanaz) Behnia
article en

Abstract

We present a patient with biochemical recurrence after salvage radiation and combined androgen deprivation therapy with abiraterone who underwent 18 F-PSMA PET/CT for a rapidly rising prostate-specific antigen (PSA). The scan revealed an intense prostate-specific membrane antigen (PSMA)-avid focus in the cecum without an apparent CT correlate. Colonoscopy identified a smooth, 2 cm nonobstructing cecal mass, and biopsy confirmed metastatic prostate adenocarcinoma by morphology and immunohistochemistry. This case demonstrates 18 F-PSMA PET/CT detection at a low PSA level of a clinically occult metastatic lesion involving the cecum, an exceptionally rare site for prostate cancer spread. Colonoscopy and biopsy confirmation of atypical PSMA-avid gastrointestinal lesions remain essential, as physiologic colonic uptake, PSMA-avid diverticula, and PSMA-expressing primary colorectal cancers are well-documented mimickers.

Clinical Nuclear Medicine
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon